FMO5 and COVID-19: CYBB, also named NADPH oxidase (mainly Nox2), was proven to play a crucial role in vascular and cerebral oxidative stress and inflammation [36], and Nox2 activation stimulates oxidative stress and associates with a severe course and thrombotic events in COVID-19 patients [37].